Skip to main content
Robert Ratner, MD, Endocrinology, Washington, DC, MedStar Washington Hospital Center

RobertEdwardRatnerMD

Endocrinology • Washington, DC

Diabetes, Lipid Metabolism

Professor, Medicine, Georgetown University School of Medicine

Join to view full profile

Dr. Ratner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ratner's full profile

Already have an account?

Summary

  • Dr. Robert Ratner is an endocrinologist in Washington, DC on faculty in the Division of endocrinology and metabolism at Georgetown University. He is chief medical officer at Virta Health. He received his medical degree from Baylor College of Medicine and has been in practice 40 years. He Served as chief scientific and medical officer for the American Diabetes Association from 2012-2016.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1982
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1977 - 1980
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1977

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1993 - 2017
  • DC State Medical License
    DC State Medical License 1982 - 2013

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Clinical Diabetes and Endocrinology in 2013 
    National Jewish Health, Snowmass, Colorado - 1/19/2013
  • Practical Ways to Achieve Targets in Diabetes Care 
    University of Colorado Denver, Keystone, Colorado - 7/12/2012

Press Mentions

  • Diabetes Reversal Leader Virta Health Demonstrates Promising Results on Mitigating COVID-19 Severity for People with Type 2 Diabetes
    Diabetes Reversal Leader Virta Health Demonstrates Promising Results on Mitigating COVID-19 Severity for People with Type 2 DiabetesJune 28th, 2021
  • No Mention of Diabetes, Virus-Deaths Link
    No Mention of Diabetes, Virus-Deaths LinkSeptember 23rd, 2020
  • Tech Entrepreneurs' Newest Ally: The FDA
    Tech Entrepreneurs' Newest Ally: The FDAApril 24th, 2020
  • Join now to see all

Grant Support

  • Diabetes Prevention Program Outcomes Study - Phase 2National Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
  • The Metformin-Exenatide-Insulin (MEXELIN) TrialNational Center For Research Resources2008–2009
  • Long Term DPP Follow-Up StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2008
  • Stop Atherosclerosis In Native Diabetics Study (SANDS)National Heart, Lung, And Blood Institute2006–2007
  • Inhaled Insulin Using The Aerx IDMS VS SC Insulin VIA SyNational Center For Research Resources2005
  • Diabetes Prevention ProgramNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2002
  • Diabetes Prevention Program (Ddd-2)National Institute Of Diabetes And Digestive And Kidney Diseases1998
  • Primary Prevention TrialNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1995

Hospital Affiliations

Dr. Robert Ratner, Dr. Robert Ratner, MD, Dr. R Ratner, Dr. Robert Edward Ratner